The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Vesitirim 1 mg/ml oral suspension

Astellas Pharma Co. LtdPA1241/009/003

Main Information

Trade NameVesitirim 1 mg/ml oral suspension
Active SubstancesSolifenacin succinate
Dosage FormOral suspension
Licence HolderAstellas Pharma Co. Ltd
Licence NumberPA1241/009/003

Group Information

ATC CodeG04BD Drugs for urinary frequency and incontinence
G04BD08 solifenacin


License statusAuthorised
Licence Issued09/10/2015
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back